Search results
Results From The WOW.Com Content Network
Employer. Novo Nordisk (since 1994) Lars Fruergaard Jørgensen (born 29 November 1966) [ 1] is a Danish businessman, the Chief Executive of Novo Nordisk since January 2017 and Chairman of the European Federation of Pharmaceutical Industries and Associations . He was named as the Financial Times Person of the Year in December 2023.
October 10, 1954 (age 69) Education. The Royal Veterinary and Agricultural University, University of Copenhagen. Occupation (s) Former CEO at Novo Nordisk, chair of Novo Nordisk Foundation (2020. Employer. Novo Nordisk (until 2016) Lars Rebien Sørensen (born 10 October 1954) [1] is a Danish businessman and former CEO of the pharmaceutical ...
Lotte Bjerre Knudsen. Lotte Bjerre Knudsen (born March 10, 1964) is a Danish scientist and university professor. She led the development of liraglutide and semaglutide, [third-party source needed] two notable drugs approved for indications in the treatment of diabetes and obesity. [ 1] [third-party source needed]
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd [ 3] with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares.
Novo Nordisk announced the largest private life science investment in state history Monday, committing $4.1 billion to expand its Johnston County facility, a project the Danish drugmaker says will ...
Paying a high premium for Novo Nordisk stock may be justifiable based on the company's significant growth opportunities. ... Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 ...
Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy ...
Honours. Knight of Order of the Dannebrog. Mads Krogsgaard Thomsen (born December 27, 1960) is a Danish businessman, CEO of the Novo Nordisk Foundation [ 1][ 2][ 3] and former Executive Vice President of Research & Development, head of R&D and Chief Scientific Officer (CSO) at the pharmaceutical company Novo Nordisk. [ 4]